Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by fasttrack5on Nov 08, 2017 11:18am

123 Views

Post# 26925518

RE:RE:Results are as expected.

Quattro74 I believe Theralase will do well eventually probably 2018 its just frustrating when one could have sold yesterday at .42 and now rebought for a nice profit - however you pay your money and take your chances.
I was averaged at .44 now I will wait and watch.
Lets hope for a successful trial with the 6 patients.
RJ.

Bullboard Posts

AI companies to invest in